Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.255 USD | +3.56% | +8.81% | -7.76% |
May. 16 | AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft | MT |
May. 02 | Transcript : AxoGen, Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.76% | 264M | |
+11.97% | 227B | |
+15.67% | 197B | |
+18.27% | 141B | |
+30.58% | 110B | |
+0.65% | 64.15B | |
+17.48% | 53.72B | |
+5.82% | 51.75B | |
+11.17% | 45.2B | |
+5.60% | 37.37B |
- Stock Market
- Equities
- AXGN Stock
- News AxoGen, Inc.
- AxoGen Files $100 Million Mixed-Securities Shelf